A carregar...
Challenging the standard of care in advanced melanoma: focus on pembrolizumab
The last several years have seen a dramatic rise in the number of effective therapies that have been shown to improve survival outcomes for patients with advanced melanoma. Among these treatments are the immune checkpoint inhibitors, a new class of immunotherapy, that have demonstrated the ability t...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5626384/ https://ncbi.nlm.nih.gov/pubmed/29026335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S92546 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|